Tag: shot
Russia skips ahead in COVID vaccine race, triggering outcry over unproven...
As global vaccine players rush to deliver COVID-19 vaccines, Russia shocked the world Tuesday with news that it had approved a locally developed inoculation. But that approval was...
Moderna prices coronavirus shot at up to $37 per dose for...
Moderna has already put out a price tag for its yet unapproved COVID-19 vaccine candidate—and so far, it's the biggest yet.
The Massachusetts biotech’s charging...
AstraZeneca reaches supply deal with Brazilian government to produce millions of...
As COVID-19 continues to rampage across the globe, Brazil stands alongside the U.S. as the countries hardest hit with new infections and deaths. But...
Moderna aims for light-speed COVID-19 shot rollout with Catalent fill-finish deal
With the search for a COVID-19 vaccine in hyperdrive, drugmakers have signed a wave of massive manufacturing tie-ups to help secure capacity for a...
AstraZeneca CEO Soriot says fast-tracked COVID-19 shot will protect for just...
AstraZeneca, advancing a COVID-19 vaccine from the University of Oxford, is among global frontrunners in the worldwide hunt for a viable vaccine. Now, the drugmaker’s CEO...
Merck’s Keytruda flops bladder cancer trial, giving Roche’s Tecentriq an open...
Merck & Co.’s Keytruda has several clinical wins under its belt that have led to a long list of FDA approvals. But it can’t...
Left out of Warp Speed, Novavax scores $60M defense contract for...
Novavax wasn’t included in the U.S. government’s group of COVID-19 vaccine finalists for Operation Warp Speed, but only days after news of those picks broke,...
Sanofi CEO: Up-front funding wins U.S. first access to coronavirus shot
As questions swirl over equitable access to COVID-19 vaccines, Sanofi CEO Paul Hudson has laid out some of his company’s plans should its program...
With nod in older adults, Merck drives HPV shot Gardasil 9...
With HPV vaccine uptake slow to take off in the U.S. way back when, Merck & Co.'s Gardasil shots missed out on many eligible patients....
